Latest

Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines.

VRX Silica Announces $3 Million Capital Raising Initiative

Australia, Business News, Latest, Most Popular, Top Stories, VRX Silica

VRX Silica Limited (ASX: VRX) (VRX Silica or Company), an advanced pureplay silica sand company led by MD Bruce Maluish, has announced a...
Read More Read More: VRX Silica Announces $3 Million Capital Raising Initiative

Platina Strikes Golden Deal: Sells Scandium Project for a Whopping US$14 Million!

Australia, Latest, Most Popular, Platina Resources, Top Stories

Platina Resources (ASX: PGM) announces the sale of its Platina Scandium Project to Rio Tinto for up to US$14 million. PLATINA SCANDIUM...
Read More Read More: Platina Strikes Golden Deal: Sells Scandium Project for a Whopping US$14 Million!
Close Search Window
Close